Immunity
Volume 32, Issue 1, 29 January 2010, Pages 91-103
Journal home page for Immunity

Article
Prolonged Interleukin-2Rα Expression on Virus-Specific CD8+ T Cells Favors Terminal-Effector Differentiation In Vivo

https://doi.org/10.1016/j.immuni.2009.11.010Get rights and content
Under an Elsevier user license
open archive

Summary

CD25, the high-affinity interleukin-2 (IL-2) receptor α chain, is rapidly upregulated by antigen-specific CD8+ T cells after T cell receptor stimulation. Here, we demonstrate that during an acute viral infection, CD25 expression is quite dynamic—after initial upregulation, a subset of virus-specific T cells sustains CD25 expression longer than the rest. At this time when there is distinct heterogeneity in CD25 expression, examination of the in vivo fate of effector cells revealed that CD25lo cells, which are relatively less sensitive to IL-2, preferentially upregulate CD127 and CD62L and give rise to functional long-lived memory cells. In contrast, CD25hi cells perceiving prolonged IL-2 signals proliferate more rapidly, are prone to apoptosis, exhibit a more pronounced effector phenotype, and appear to be terminally differentiated. Consistent with this, sustained IL-2 receptor signaling during expansion drove terminal-effector differentiation. These data support the hypothesis that prolonged IL-2 signals during priming promote terminal-effector differentiation.

Highlights

► Acute viral infection induces dynamic IL-2Rα expression on CD8+ T cells ► Transient heterogeneity in IL-2Rα marks distinct memory fates ► IL-2Rαhi cells preferentially give rise to KLRG-1hi CD127lo cells ► Prolonged IL-2 signaling drives terminal effector differentiation

Cited by (0)

5

These authors contributed equally to this work